Last month we had the honor of hosting a mission of 25 Jewish business leaders from California. The opportunity to meet with this energetic group and to show them our leading-edge companies provided us with a great reminder of our vision:

We take great pride in showcasing our companies and their accomplishments to visitors (and our newsletter readers). And we thank the mission participants for helping us recharge our batteries.

If you are planning a visit or organizing a mission to Israel, we would be happy to arrange a visit for you and your group to the Misgav Venture Accelerator. If you can't make it in person, then we hope our newsletter gives you a glimpse into the exciting developments taking place at Misgav.

Steve Rhodes, CEO
Misgav Venture Accelerator

NEWS

Welcome to Our Newest Portfolio Company: Juvenis
Juvenis is developing Tenrgel™ technology, an innovative gel-like material that can be used to fill, repair, or augment soft tissue. The biodegradable liquid polymer increases in viscosity when exposed to tissue and fluids. It has a pre-programmed duration ranging from 1 month to 24 months, after which it breaks down into natural compounds. Tenrgel is hypoallergenic and very effective. Dr. Lior Yankelson, Misgav's VP business development, is the founding entrepreneur.

We welcomed Neuroquest earlier this year. Read more about Neuroquest's diagnostic kits for neurodegenerative diseases.


MCL Receives Investment from Samsung Ventures 
Misgav graduate MCL Micro Components has received an investment of several million dollars from Samsung Ventures Investment Corp. Learn more about MCL Micro Components.


Virtual Ports Receives FDA Approval for Second Product
Virtual Ports has received its second FDA approval -- this time for EndoClear. The company's first product, EndoGrab, was approved by the FDA last year. Learn more about Virtual Ports.


Lavi Cardiatec Begins Clinical Trials
Lavi Cardiatec started clinical trials for its Endotect device at Israel's Sheba Medical Center. Read the full story.


JetGuide Starts Clinical Trials
JetGuide is performing experiments in the Department of Oral & Dental Medicine & Unit of Periodontology at Rambam Health Care Campus (RHHC) in Haifa, Israel. Read the full story.


ETView Names New Chairman
ETView has named Jonathan Adereth as its new chairman. A veteran of the Israeli medical imaging industry, he served in a number of positions at Elscint, a leading company in medical imaging. He capped his long career there as president and CEO from 1994 to 1998. Adereth serves on the boards of other Israeli companies in the medical equipment and imaging fields. Learn more about ETView.


Headway Unveils New Website
Headway has completed work on its new website. Headway is focused on developing Occiflex, a device for treating chronic head and neck pain caused by headaches and injuries. See Headway's new website.


Genova Featured in Israel 21c
Genova's technology that transforms biomass (organic waste) into energy was the subject of a feature story in Israel21c. Read the full story.


JetGuide and ProIV Present at Incubator Conference
Both JetGuide and ProIV presented at the Incubator Project Managers Conference on March 9. Learn more about JetGuide and ProIV.



EVENTS

 

See You at Biomed
We look forward to seeing you at Biomed. Stop by the Misgav booth (#41) to meet our companies and to learn about our cutting-edge life science technologies.
 
This year's Biomed is May 27-29 at the David Intercontinental Hotel in Tel Aviv.
 

Join Us at BIO
Misgav will be participating in the Israel Pavilion at the annual Bio Conference, June 17-19, San Diego, California (booth #543).



ANNOUNCEMENTS

Scott Mann has been named in-house counsel for T.I.F. Ventures, the parent company of the Misgav and Mofet incubators.

Scott has more than 25 years of legal experience in civil law, including contracts, commerce, real estate, banking, and business. He will be responsible for working with T.I.F. Ventures, the incubators, and the companies.

 

©2008 The Misgav Venture Accelerator. All rights reserved